HOME >> BIOLOGY >> NEWS
Columbia University launches multi-year campaign to support stem cell research

NEW YORK, NY, June 15, 2005 Columbia University Medical Center (CUMC) announced today that it is halfway toward realizing the first phase of a multi-year campaign to build upon the university's groundbreaking stem cell research and lead the effort to fully realize the therapeutic potential of stem cells. Of the $50 million goal for the first stage of the campaign, $25 million has been raised from the private sector, specifically for diabetes and neural stem cell research.

Columbia University Medical Center researchers are at the forefront of an extraordinary movement to revolutionize medical approaches to therapeutics through its Stem Cell Initiative. Columbia's leadership in developmental biology, neuroscience research, transplantation, and cell replacement therapy uniquely positions the university to push stem cell research forward, and more than 40 CUMC researchers are currently conducting leading stem cell studies.

"This initiative will provide our researchers with the resources necessary to fully realize the potential of stem cells," said Gerald D. Fischbach, M.D., executive vice president of Columbia University Medical Center and dean of the faculty of medicine at Columbia's College of Physicians and Surgeons. "Columbia continues to be a leader in this revolutionary health technology that holds the promise to benefit people suffering from a wide variety of debilitating health problems."

Federal restrictions on human embryonic stem cell research funding and lagging state funds have limited available government support for this emerging and promising research, prompting CUMC to reach out to the private sector with this crucial stem cell initiative.

CUMC researchers are currently exploring the vast potential of stem cells to treat a wide range of illnesses, including Parkinson's disease, amyotrophic lateral sclerosis (ALS), diabetes, pancreatic cancer, leukemia, stroke and other diseases of the nervous system, liver, eye,
'"/>

Contact: Craig LeMoult
cel2113@columbia.edu
212-305-0820
Columbia University Medical Center
15-Jun-2005


Page: 1 2 3

Related biology news :

1. Columbia University Medical Center awarded $3 million to drive Alzheimers genetics research
2. Columbia scientists determine 3-dimensional structure of cells fuel gauge
3. Columbia University licenses next-generation DNA sequencing technology
4. New bird discovered on unexplored Columbian mountain
5. Columbia University Medical Center receives major new NIH Clinical Science investment funds
6. Columbia University awards 2006 Horwitz Prize to biologist who explained gene transcription
7. Columbia University receives $16.9 million NIEHS award to study arsenic in ground water
8. Contaminants linked to sturgeon decline in Columbia river
9. Columbia University Medical Center researchers discover potential mechanism for tumor growth
10. UF, Columbia scientists closer to new cancer detection method
11. Columbia University awards 2005 Horwitz Prize to Israeli structural biologist

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. (NASDAQ: ... announces the filing of its 2016 Annual Report on Form 10-K ... Commission. ... 10-K is available in the Investor Relations section of the Company,s ... the SEC,s website at http://www.sec.gov . 2016 Year ...
(Date:4/11/2017)... 11, 2017 Research and Markets has announced ... report to their offering. ... global eye tracking market to grow at a CAGR of 30.37% ... Tracking Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
(Date:4/5/2017)... -- The Allen Institute for Cell Science today announces the ... and dynamic digital window into the human cell. The ... of deep learning to create predictive models of cell ... growing suite of powerful tools. The Allen Cell Explorer ... available resources created and shared by the Allen Institute ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit ... 7th and 8th June 2018 in San Francisco, CA. The Summit brings together current ... several distinguished CEOs, board directors and government officials from around the world to address ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. 11, ... Research, London (ICR) and University of ... SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma (MM), ... nine . The University of Leeds ... funded by Myeloma UK, and ICR will perform the testing ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
(Date:10/10/2017)... ... October 10, 2017 , ... For the second time ... US2020 STEM Mentoring Award. Representatives of the FirstHand program travelled to Washington, D.C. ... US2020. , US2020’s mission is to change the trajectory of STEM education in ...
Breaking Biology Technology:
Cached News: